Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue SarcomaPriya Chudasama, Marcus Renner, Melanie Straub, et al.
Genes, Chromosomes & Cancer|June 6, 2020
Germline SDHB-inactivating mutation in gastric spindle cell sarcomaChristoph E Heilig, Peter Horak, Daniel B Lipka, et al.
NPJ Precision Oncology|January 10, 2025
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologyIrina A Kerle, Thomas Gross, Anja Kögler, et al.
Nature Communications|May 10, 2020
The landscape of chromothripsis across adult cancer typesNatalia Voronina, John K L Wong, Daniel Hübschmann, et al.
Science Advances|September 1, 2023
BRAF<sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggabilityManuel Lauinger, Daniel Christen, Rhena F U Klar, et al.
International Journal of Cancer|June 10, 2017
Precision oncology based on omics data: The NCT Heidelberg experiencePeter Horak, Barbara Klink, Christoph Heining, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
Med (New York, N.Y.)|May 1, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasmsSimon Kreutzfeldt, Leonidas Apostolidis, Małgorzata Oleś, et al.
Nature Communications|April 11, 2019
Defective homologous recombination DNA repair as therapeutic target in advanced chordomaStefan Gröschel, Daniel Hübschmann, Francesco Raimondi, et al.
Pageof 4